The 49th annual DIA conference, which brings together the different segments of the drug development industry, officially kicks off today in Boston. Clinical trial software developers to pharmaceutical research and development teams and regulators, among others, will look at issues affecting the industry from innovations in clinical trial design, the impact of mobile devices and the use of big data to personalized medicine and regulatory changes. Here are nine industry insiders who are speaking or exhibiting at #DIA2013 to follow on Twitter.
Dr. Daniel Kraft (@daniel_kraft) is a physician and scientist at Stanford University School of Medicine, executive director of FutureMed at Singularity University and is a keynote speaker at the conference.
Ritesh Patel (@Ritters90) is the global head of inVentiv Health, a provider of drug development services for to pharmaceutical, biotechnology, generic drug, and medical device companies, which is exhibiting at DIA.